Age ≥ 18 years inclusive at the time of signing the ICF
Allogeneic SCT 90 to 180 days prior to enrollment
Able to comprehend and willing to provide informed consent
Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel
Clareo Health | Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
